Korrektur der COVID-19-Impfstoffpolitik und Moratorium für gegenwärtig zugelassene mRNA-COVID-19-Impfstoffe

This procedure calls for a review of Germany's COVID-19 vaccine policies, specifically focusing on current mRNA vaccines. It proposes a temporary halt on the use of vaccines that have already received approval. The request aims to address public concerns and ensure the safety and efficacy of vaccines. It could impact public health strategies and the pharmaceutical industry's vaccine development and deployment.